Abstract
Ketoacidosis in new-onset type 1 diabetes: return to pre-COVID-19 pandemic reality?
- Department of Paediatrics, Unidade Local de Saúde Região de Aveiro, Portugal
- Paediatric Endocrinology, Diabetes and Growth Unit, Hospital Pediátrico de Coimbra, Unidade Local de Saúde de Coimbra, Portugal
- Department of Paediatrics, Unidade Local de Saúde do Médio Tejo, Torres Novas, Portugal
- Department of Paediatrics, Unidade Local de Saúde Viseu Dão-Lafões, Viseu, Portugal
Introduction
Type 1 diabetes mellitus (T1D) is one of the most common chronic diseases in childhood, with its incidence increasing globally. The coronavirus disease 2019 (COVID-19) pandemic has been associated with an increase in severity of cases of diabetic ketoacidosis.
Aim of the study
Type 1 diabetes mellitus (T1D) is one of the most common chronic diseases in childhood, with its incidence increasing globally. The coronavirus disease 2019 (COVID-19) pandemic has been associated with an increase in severity of cases of diabetic ketoacidosis.
Material and methods
A retrospective cohort study was conducted, using patients’ clinical records, between March 2016 and March 2024. The sample was divided in three groups: pre-pandemic (March 2016 to March 2020), pandemic (March 2020 to March 2021), and post-pandemic (March 2021 to March 2024).
Results
A retrospective cohort study was conducted, using patients’ clinical records, between March 2016 and March 2024. The sample was divided in three groups: pre-pandemic (March 2016 to March 2020), pandemic (March 2020 to March 2021), and post-pandemic (March 2021 to March 2024).
Conclusions
There was an improvement in the post-pandemic period, with a lower severity at presentation. However, the rate of ketoacidosis remained high, and the focus must remain on implementing preventative measures.
Keywords
diabetes mellitus type 1, diabetic ketoacidosis, COVID-19
Integrated with
